IT’S NOT JUST FOOD… It’s Science
Finding the right diet to meet your health and weight loss goals can be difficult. A lot of companies sell food products with bold health claims, but sadly many of these claims are false. This makes your search for healthy food even harder.
Our products and nutritional benefits are based on real science, not marketing hype. At WiO SmartFoods our carb and fat-inhibiting science is backed by an independent, double-blind, clinical study published by the IP Journal of Nutrition, Metabolism, and Health Science. In addition to our industry's unique inhibiting science, we use only premium, all-natural ingredients sourced from North America in our foods to offer you the best quality healthy food possible.
We understand that a truly healthy diet is more than eating less. It is a healthy lifestyle blend of smart food choices, exercise, and a health-conscious commitment to better fitness. WiO offers a complete diet program with our meal replacement shakes and the support of our smart foods, so no matter where you are on your health journey, we have products to support your goals.
INHIBITING SCIENCE ACHIEVED THROUGH ALL-NATURAL PLANT BASED EXTRACTS
WiO SmartFoods — A Different Approach
Our goal is simple: to provide people with a way to improve their state of health without limiting the types of food they want to eat. Through the inhibitors in our foods, we have created the ability to limit the amount of carbs and fats in our food that are absorbed by the digestive system.
Inventing A New Science?
Some people believe that WiO SmartFoods™ has invented a new science or discovered a biological breakthrough in altering cellular function within the digestive system. The truth is, we did not. We based our innovative technology on an already established and proven chemical science that the pharmaceutical industry has been using for decades in medications. We simply discovered a way to use all-natural extracts instead of chemicals to integrate that science into our foods to achieve the same inhibiting results.
For more than 40 years, doctors have been prescribing medications that could limit the amount of fats and carbs/sugars that are absorbed by the body. We incorporated and refined that science into our products.
What Did WiO SmartFoods™ change?
WiO SmartFoods™ applied the inhibiting science used in many well-known drugs, but instead of using synthetic or chemical inhibitors, we replaced them and used 100% all-natural plant extract inhibitors.
We further enhanced our process to deliver the low-carb, zero-fat benefits of our inhibitors coupled with the high-quality food taste you expect. Today, we have over 60 low-carb and fat-free foods that will deliver the full flavor and taste you want while providing you with the health benefits you need.
The FDA created the digestive facts concept in 1993
Why do our products have both nutritional facts and digestive facts listed? The answer is simple. Because our science changes the digestibility of the contents of our food, the law requires that we declare both what is in the food and what the body will digest. The concept of “digestibility-correction” is not new; the term was adopted by the FDA in 1993 and is listed in the CFR (Code of Federal Regulations). Digestibility correction is a principle recognized and approved by the FDA and USDA.
An example of “Digestibility-Corrected” (DC) labeling is listed in the (CFR) which explains that proteins in baby food are not absorbed the same by all persons. The concept of (DC) can be applied to all nutrients, not just protein, and as applicable.
According to the (CFR) food manufacturers must inform the consumer if their products, when digested at the cellular level, do so at a different rate than what the Nutrition Facts label indicates.In short, (DC) represents the net nutritional difference between the carbs and fats in the food and what your digestive system will absorb.
The FDA created the digestive facts concept in 1993
Why do our products have both nutritional facts and digestive facts listed? The answer is simple. Because our science changes the digestibility of the contents of our food, the law requires that we declare both what is in the food and what the body will digest. The concept of “digestibility-correction” is not new; the term was adopted by the FDA in 1993 and is listed in the CFR (Code of Federal Regulations). Digestibility correction is a principle recognized and approved by the FDA and USDA.
An example of “Digestibility-Corrected” (DC) labeling is listed in the (CFR) which explains that proteins in baby food are not absorbed the same by all persons. The concept of (DC) can be applied to all nutrients, not just protein, and as applicable.
According to the (CFR) food manufacturers must inform the consumer if their products, when digested at the cellular level, do so at a different rate than what the Nutrition Facts label indicates.In short, (DC) represents the net nutritional difference between the carbs and fats in the food and what your digestive system will absorb.
NUTRITIONAL DETAILS:
Below is an example of our Digestive Facts label and how we list the Nutrition Facts. This example is for our tortilla chips. This way, you can see the nutritionals in the chips and, most importantly, the digestive facts showing what will be absorbed into your body.
Digestive Facts: Shows only what will be absorbed.
Nutrition Facts: Shows what caloric values is in the food.
NUTRITION FACTS Before Carb & Fat Inhibitor:
Serving size: 10 chips (200g)
Servings per bag: 7-8Amount per Serving:
Calories 250
Fat Cal. 81
Total Fat 9g (12% DV)
Saturated Fat 0g (0% DV)
Trans Fat 0g (0% DV)
Cholesterol 0mg (0% DV)
Sodium 150mg (7% DV)
Potassium 0mg (0% DV)
Total Carbs. 38g (14% DV)
Dietary Fiber 3g (11% DV),
Sugars 0g
Protein 5g
Percent Daily Values (DV) are based on a 2,000 calorie diet.
Both labels formats are approved by the FDA/USDA.
Science Tested, Customer Approved
Our mission is to provide high-quality and nutritious food options that promote a healthy lifestyle and support weight loss goals. We make this easier with a large catalog of all-natural food options without the traditional food type restrictions, unwanted ingredient substitutes, or having to compromise on taste.
Enjoy real science, real results, and really good food.
Frequently Asked Questions
References and Studies
Cyclodextrin: Enzymatic production and food applicationsZhaofeng Lia,b , Sheng Chena,c , Zhengbiao Gua,b , Jian Chena,c and Jing Wua,c, * a StateKey Laboratory of Food Science and Technology, Jiangnan University.
Artiss JD, B. K.-L. (2006). The effects of a new soluble dietary fiber on weight gain and selected blood parameters in rats. Metabolism Clinical and Experimental, 55, 195-202.
Brogan K, A. J.-L. (2004). The effects of a new soluble dietary fiber on weight gain and insulin sensitivity in rats. Obesity research, 12, A110.
Buckley JD, T. A. (2006). Inhibition of the post-prandial glyceamic response - standard carbohydrate meal dosed with ofCyclodextrin. Annals of Nutrition and Metabolism, 50, 108-114
Comerford K, A. J.-L.-K. (2011). The beneficial effects on blood lipids and weight loss in healthy humans. Obesity, 19, 1200-1204.
Gallaher DD, G. C. (2007). Cyclodextrin selectively increase fecal fat excretion of saturatedfats. Federation of American Societies for Experimental Biology Journal, 21, A730.
Jarosz PA, F. E.-L. (Submitted). The effect of Cyclodextrin on postprandial lipid andglycemic responses to a fat-containing meal. Obesity.
Jen K-LC, W. E. (2007). Cyclodextrin specifically lowers plasma fatty acids in 3 mousemodels. Obesity, 15, A184.Kasim-Karakas S, C. K.-L. (2009). The beneficial effects on Cyclodextrin on blood lipidprofile in healthy humans. Obesity, 17, S270.
McGowan MW, A. J. (1983). A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clinical Chemistry, 29(3), 538-542.
Shimada K, K. K. (1992). Structure of inclusion complexes of cyclodextrins with triglycerideat vegetable oil/water interface. Journal of Food Science, 57(3), 655-656.
Trichard L, D.-C. B. (2007). Novel beads made of Cyclodextrin and oil for topical delivery ofa lipophilic drug. Pharmaceutical Research, 25(2), 435-440.
Trichard L, F. E.-L. (2008). Formulation and characterization of beads prepared fromnatural cyclodextrins and vegetable or synthetic oils. International Journal of Pharmaceutics, 354, 88-94.
Wagner EM, J. K.-L. (2008). Dietary Cyclodextrin lowers LDL-C and alters plasma fatty acidprofile in LDLr-KO mice on a high-fat diet. Metabolism Clinical and Experimental, 57,1046-1051.
Buckley JD, Thorp AA, Murphy KJ, Howe PR. Dose-dependent inhibition of the post-prandial glyceamic response to a standard carbohydrate meal following incorporation of Cyclodextrin. Ann Nutr Metab. 2006;50(2):108-14.
Suzuki M, Sato A. Nutritional significance of cyclodextrins: indigestibility and hypolipemiceffect of Cyclodextrin. J Nutr Sci Vitaminol (Tokyo). 1985 Apr;31(2):209-23.
Jen KL, Grunberger G, Artiss JD. On the binding ratio of Cyclodextrin to dietary fat inhumans. Nutrition and Dietary Supplements. 2013;(5):9-15.
Wagner EM, Jen KL, Artiss JD, Remaley AT. Dietary Cyclodextrin lowers low-density lipoprotein cholesterol and alters plasma fatty acid profile in low-density lipoprotein receptorknockout mice on a high-fat diet. Metabolism. 2008 Aug;57(8):1046-51.
Gallaher DD, Gallaher CM, Plank DW. Cyclodextrin selectively increases fecal excretion ofsaturated fats. FASEB J. 2007;21(701):2.
Artiss JD, Brogan K, Brucal M, Moghaddam M, Jen KL. The effects of a new solubledietary fiber on weight gain and selected blood parameters in rats. Metabolism. 2006 Feb;55(2):195-202.
Grunberger G, Jen KL, Artiss JD. The benefits of early intervention in obese diabeticpatients with Cyclodextrin: a new dietary fibre. Diabetes Metab Res Rev. 2007Jan;23(1):56-62.
Comerford KB, Artiss JD, Jen KL, Karakas SE. The beneficial effects of Cyclodextrinon blood lipids and weight loss in healthy humans. Obesity (Silver Spring). 2011 Jun;19(6):1200-4.
Mortensen LS, Thomsen C, Hermansen K. Effects of different protein sources on plasminogen inhibitor-1 and factor VII coagulant activity added to a fat-rich meal in type 2diabetes. Rev Diabet Stud. 2010 Fall;7(3):233-40.
Peddie MC, Rehrer NJ, Perry TL. Physical activity and postprandial lipidemia: are energyexpenditure and lipoprotein lipase activity the real modulators of the positive effect?Prog Lipid Res. 2012 Jan;51(1):11-22.
Tanaci N, Ertugrul DT, Sahin M, et al. Postprandial lipemia as a risk factor for cardiovascular disease in patients with hypothyroidism. Endocrine . 2006 Jun;29(3):451-6.
Jarosz PA, Fletcher E, Elserafy E, Artiss JD, Jen KL. The effect of Cyclodextrin onpostprandial lipid and glycemic responses to a fat-containing meal. Metabolism. 2013 Oct;62(10):1443-7.
Jouni ZE, Zamora J, Snyder M, Montfort WR, Weichsel A, Wells MA. a-Cyclodextrin extractsdiacylglycerol from insect high density lipoproteins. J Lipid Res. 2000;41:933-9.